![Gold prices soften, see little relief from increased rate cut bets](https://i-invdn-com.investing.com/news/Gold_150x108_S_1609947477.jpg)
Please try another search
For the six months ended 30 June 2019, Evoke Pharma Inc revenues was not reported. Net loss decreased 5% to $4.1M. Lower net loss reflects Interest Income increase from $4K to $14K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.27 to -$0.20.
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -2.12 | -1.97 | -1.77 | -1.52 |
Net Income | -2.11 | -1.97 | -1.76 | -1.52 |
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Total Assets | 7.63 | 4.36 | 5.66 | 7.02 |
Total Liabilities | 1.29 | 1.29 | 1.63 | 1.61 |
Total Equity | 6.35 | 3.08 | 4.03 | 5.41 |
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -3.56 | -1.93 | -6.98 | -5.73 |
Cash From Investing Activities | ||||
Cash From Financing Activities | 5.68 | 0.64 | 4.62 | 4.62 |
Net Change in Cash | 2.12 | -1.29 | -2.36 | -1.11 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review